Embecta Corp (EMBC)
Company Info
Highlights
$658.06M
$0.83
12.71
$1.08B
$685.10M
$201.90M
$10.13 - $20.80
$17.75
7.06%
5.18
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Embecta Corp (EMBC) returned -48.11% year-to-date (YTD) and -14.34% over the past 12 months.
EMBC
-48.11%
-15.64%
-47.56%
-14.34%
-23.97%
N/A
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of EMBC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -13.17% | -23.86% | -5.56% | -4.39% | -13.07% | -48.11% | |||||||
| 2024 | -9.46% | -15.82% | -7.07% | -23.66% | 23.53% | 1.05% | 25.36% | 5.39% | -13.71% | -0.14% | 47.94% | -0.11% | 13.55% |
| 2023 | 4.35% | 21.64% | -11.99% | -1.32% | 0.25% | -21.94% | -1.20% | -13.37% | -17.89% | 0.47% | 21.30% | 4.07% | -23.11% |
| 2022 | -0.23% | -18.57% | 2.18% | 16.23% | 8.97% | -9.81% | 7.40% | 6.47% | -22.73% | -16.21% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of EMBC is 36, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Embecta Corp (EMBC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Embecta Corp provided a 5.74% dividend yield over the last twelve months, with an annual payout of $0.60 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Dividend | $0.60 | $0.60 | $0.60 | $0.30 |
Dividend yield | 5.74% | 2.91% | 3.17% | 1.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Embecta Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.30 | |||||||
| 2024 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2023 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2022 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.30 |
Dividend Yield & Payout
Dividend Yield
Embecta Corp has a dividend yield of 5.74%, which means its dividend payment is significantly above the market average.
Payout Ratio
Embecta Corp has a payout ratio of 23.62%, which is below the market average. This means Embecta Corp returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Embecta Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Embecta Corp was 70.19%, occurring on Apr 30, 2024. The portfolio has not yet recovered.
The current Embecta Corp drawdown is 67.52%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -70.19% | Dec 14, 2022 | 345 | Apr 30, 2024 | — | — | — |
| -28.06% | Apr 14, 2022 | 64 | Jul 18, 2022 | 20 | Aug 15, 2022 | 84 |
| -16.63% | Aug 22, 2022 | 34 | Oct 7, 2022 | 25 | Nov 11, 2022 | 59 |
| -6.45% | Nov 14, 2022 | 4 | Nov 17, 2022 | 11 | Dec 5, 2022 | 15 |
| -6.37% | Apr 5, 2022 | 3 | Apr 7, 2022 | 1 | Apr 8, 2022 | 4 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Embecta Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Embecta Corp, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 19.1% positive surprise.
Valuation
The Valuation section provides an overview of how Embecta Corp is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for EMBC, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, EMBC has a P/E ratio of 12.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EMBC relative to other companies in the Medical Instruments & Supplies industry. Currently, EMBC has a P/S ratio of 0.6. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for EMBC in comparison with other companies in the Medical Instruments & Supplies industry. Currently, EMBC has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |